We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 3,472

FTC Action Against Physician Cooperative Illustrates Risks of Collective Contracting Activity Among Independent Providers
  • Reed Smith LLP
  • Puerto Rico, USA
  • March 3 2017

The FTC charged that OFTACOOP (also known as Cooperativa de Médico Oftalmólogos de Puerto Rico), a Puerto Rico ophthalmologist cooperative with about


FTC Action Against Physician Cooperative Illustrates Risks of Collective Contracting Activity Among Independent Providers
  • Reed Smith LLP
  • USA
  • March 1 2017

A recent Federal Trade Commission (“FTC”) enforcement action against a physician cooperative in Puerto Rico for organizing a group boycott of a


The Government Seeks to Intervene in its Third Generic Drug Price-fixing Lawsuit
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • February 28 2017

Since we last reported on the state and federal Government’s generic drug pricing investigations and litigations (click here to read more), the U.S


The FTC and Overlapping Boards
  • McDermott Will & Emery
  • USA
  • February 27 2017

Important new guidance from the Federal Trade Commission (FTC) underscores the value of antitrust compliance when health systems use interlocking


Life sciences: product regulation and liability in the USA
  • Perkins Coie LLP
  • Global, USA
  • February 24 2017

A structured guide to product regulation and liability in the USA


NAD shoots down Bowflex’s claims of dramatic weight loss as unsupported; disclaimer not enough
  • Porter Wright Morris & Arthur LLP
  • USA
  • February 24 2017

Nautilus’s Bowflex TreadClimber just became the latest example of enforcement action against a health and fitness product by the National Advertising


DOJ Successfully Blocks Insurance Mergers: What Are the Takeaways?
  • Manatt Phelps & Phillips LLP
  • USA
  • February 22 2017

In July 2016, following a lengthy review, the Antitrust Division of the Department of Justice (DOJ), together with several states, sued to block two


A tale of two mergers: Following their losses in DOJ merger challenges, Anthem fights on and Aetna gives up
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • February 17 2017

In the past month, the DOJ and several state governments scored two trial wins in their challenges to mergers among some of the country’s largest


What to Expect From FTC during Trump Administration: New Leader Illuminates
  • Baker & Hostetler LLP
  • USA
  • February 16 2017

On Jan. 25, President Trump named Maureen Ohlhausen as the Federal Trade Commission’s acting chairwoman. A recent speech by Ohlhausen, who has served


Beyond Pay-for-Delay: Three Pharma Antitrust Cases To Watch In 2017
  • Paul Hastings LLP
  • USA
  • February 16 2017

While courts continue to grapple with the implications of the Supreme Court’s landmark decision in FTC v. Actavis, Inc.,1 the potential for